Journey Medical Promotes Ramsey Alloush to COO Amid Growth
Journey Medical Corporation Appoints New Chief Operating Officer
Journey Medical Corporation (NASDAQ: DERM) is thrilled to announce the elevation of Ramsey Alloush from his position as General Counsel to the role of Chief Operating Officer (COO). This strategic move comes at a crucial time as the company gears up for the launch of its innovative product, Emrosi™.
Leadership Insights
Claude Maraoui, the company's President and CEO, highlighted Mr. Alloush's invaluable contributions to the organization, stating, "Ramsey’s promotion to COO exemplifies the outstanding leadership qualities he has consistently displayed. His insight into our operational framework and industry dynamics will play a key role in propelling Journey Medical's ambitions forward."
Ramsey Alloush's Vision
Expressing his excitement over the new role, Mr. Alloush remarked, “It's an honor to step into this pivotal position at a time when we're set to introduce a groundbreaking product into the dermatology market. Emrosi™ represents our dedication to enhancing patient care through innovative treatments.” He emphasized that the company's vision extends beyond mere therapeutic advancements—it's about reshaping the industry landscape.
Experience and Background
Joining Journey Medical in 2020, Alloush brought with him a wealth of experience totaling over 15 years in the pharmaceutical sector. Throughout his career, he has expertly navigated complex legal landscapes, overseen crucial financing operations, including the company's initial public offering in 2021, and guided corporate governance initiatives. His profound understanding of industry regulations has been instrumental to the firm's ongoing success.
A Look at His Career Milestones
Before joining Journey Medical, Ramsey provided advisory services to various biopharmaceutical companies regarding corporate and securities transactions. Notably, he also served as a legal fellow at the Securities and Exchange Commission, focusing on enforcement issues. Earlier in his career, he contributed to the Aesthetics Division at Medicis Pharmaceuticals, which was subsequently acquired by Valeant Pharmaceuticals for $2.6 billion.
About Journey Medical Corporation
Journey Medical Corporation (NASDAQ: DERM) is dedicated to the commercialization of FDA-approved pharmaceutical products aimed at treating dermatological ailments. Operating through a robust sales model, the company currently markets eight prescription drugs designed to alleviate common skin conditions. Journey Medical prides itself on having a team comprised of industry veterans with substantial success in developing and launching top-tier dermatological brands.
Company Vision and Future Directions
With its headquarters located in Scottsdale, Arizona, Journey Medical continues to strive for excellence in the pharmaceutical industry, driven by a commitment to innovation and patient care. Founded by Fortress Biotech, Inc. (NASDAQ: FBIO), the organization’s common stock is officially registered under the Securities Exchange Act of 1934, ensuring compliance and transparency through routine updates to the U.S. Securities and Exchange Commission.
For further details regarding Journey Medical's initiatives, stakeholders can reach out to:
Jaclyn Jaffe
Journey Medical Corporation
(781) 652-4500
ir@jmcderm.com
Media Relations Contact:
Tony Plohoros
6 Degrees
(908) 591-2839
tplohoros@6degreespr.com
Frequently Asked Questions
Who is the new COO of Journey Medical Corporation?
Ramsey Alloush has been promoted to Chief Operating Officer of Journey Medical Corporation.
What product is Journey Medical preparing to launch?
The company is preparing for the launch of Emrosi™, which aims to set a new standard of care in dermatology.
What is Ramsey Alloush's professional background?
Mr. Alloush has over 15 years of experience in the pharmaceutical industry, having served as General Counsel before his promotion.
How many FDA-approved products does Journey Medical market?
Journey Medical currently markets eight FDA-approved prescription drugs for treating dermatological conditions.
What is the company's mission?
Journey Medical is dedicated to enhancing patient care through innovative pharmaceutical solutions and operational excellence.
About The Author
Contact Lucas Young privately here. Or send an email with ATTN: Lucas Young as the subject to contact@investorshangout.com.
About Investors Hangout
Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/
The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.
